MedTrace Logo

The Asian Transcatheter Aortic Valve Replacement Registry

NCT02308150 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1505

Last updated 2019-09-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve replacement (TAVR) in the Asian Pacific population

Conditions

  • Aortic Valve Stenosis
  • Aortic Diseases

Interventions

DEVICE

transcatheter aortic valve replacement

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Seung-Jung Park

    lead OTHER

Principal Investigators

  • Seung-jung Park, MD · Asan Medical Center

  • Paul Hsien Li Kao, MD · National Taiwan University

  • Shigeru Saito, MD · Shonan Kamakura General Hospital, Japan

  • Gerald Yong, MD · Royal Perth Hospital, Australia

  • Kentaro Hayashida, MD · Keio University, JAPAN

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2019-09-24
Completion
2019-09-24

Countries

  • China
  • Japan
  • Singapore
  • South Korea
  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308150 on ClinicalTrials.gov